GNFT (GENFIT) Earnings per share for the last twelve months

Public company logo of Genfit SA (GNFT)

The price trend based on the EPS (TTM) metric for Genfit S.A. (GNFT) is -275.50. Genfit S.A. (GNFT) management has effectively restructured operations toward partnership schemes following the divestment of its primary asset. The business relies on creating unique compounds for the therapy of orphan bile duct pathologies, which guarantees pricing power. The operating model is based on outsourcing production and testing to third-party contractors.

GENFIT (GNFT): Earnings per share for the last twelve months from 02/11/2024 to 12/06/2025

Genfit Corp - analytical breakdowns and key metrics (GNFT)

- market price and analyst price targets:
- business market valuation indicators:
Initial company analysis:Genfit SA, GNFT
Signature product of Genfit SA

The investment attractiveness of Genfit S.A. (GNFT) depends on the company's ability to transform scientific research into actual profit. This indicator captures the dynamics of net earnings per share over the last twelve months relative to the previous year. By analyzing the rolling EPS YoY change, an investor can see the impact of high R&D expenses and revenue deficits on capitalization. The negative trend here reflects the depletion of reserves, determining the real value of the business.